Clinical Trial Update: Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial studying human umbilical cord-derived mesenchymal stem cells for lupus nephritis; the current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Human Umbilical Cord-derived Mesenchymal Stem Cells (mesenchymal stem cells)

Snippet

Sponsor: CytoMed & Beike | Conditions: Lupus Nephritis | Phase 2 | Status: UNKNOWN